Clinical Trial Update: Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating voriconazole to prevent fungal infections in children with neutropenia after chemotherapy. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Neuroblastoma
• Sarcoma

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer, Leukemia | Phase 2 | Status: COMPLETED